GSRX Industries Inc. Share Price Other OTC
Equities
GSRX
US36255V1070
Pharmaceuticals
Sales 2018 | 2.68 211.79 | Sales 2019 | 11 869.14 | Capitalization | 1.34M 106M |
---|---|---|---|---|---|
Net income 2018 | -16M -1.26B | Net income 2019 | -36M -2.84B | EV / Sales 2018 | 26,486,381 x |
Net cash position 2018 | 1.31M 104M | Net Debt 2019 | 2.27M 179M | EV / Sales 2019 | 328,290 x |
P/E ratio 2018 |
-4.29
x | P/E ratio 2019 |
-0.03
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 13.26% |
Managers | Title | Age | Since |
---|---|---|---|
Troy Nihart
CEO | Chief Executive Officer | 46 | 09/03/20 |
Director of Finance/CFO | 63 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Troy Nihart
CEO | Chief Executive Officer | 46 | 09/03/20 |
Jeff Rogers
BRD | Director/Board Member | 61 | 09/03/20 |
Shaun Dale
BRD | Director/Board Member | 47 | 22/04/20 |
1st Jan change | Capi. | |
---|---|---|
+51.99% | 798B | |
-5.72% | 356B | |
+18.94% | 328B | |
+11.07% | 304B | |
+16.96% | 244B | |
+2.25% | 227B | |
+11.15% | 216B | |
+7.59% | 166B | |
-3.65% | 157B |